$PRFX News

PRF Technologies Provides First Half 2026 Business Update Highlighting Significant Progress Across Healthcare and AI Energy Business

PRF Technologies Issues Letter to Shareholders Highlighting Strengthened Financial Position and Building Momentum Across Its Biotechnology and AI-Driven Energy Platforms

PRF Technologies Issues Shareholder Letter Regarding Stronger Financial Position, Diversified Portfolio Of Innovative Technology Businesses, Real Commercial Momentum And Increased Strategic Flexibility

PRF Technologies to Showcase GridFeed™ at Energy Trading Week Europe 2026

PRF Technologies Expands DeepSolar Predict™ Platform with Battery-to-Revenue Intelligence, Extending AI-Driven Revenue Optimization Across Solar and Energy Storage Assets

PRF Technologies Expands Its DeepSolar Predict AI Renewable Energy Sales Optimization Platform With Battery-To-Revenue Intelligence Functionality

PRF Technologies’ DeepSolar Successfully Validates Predict™ AI Platform for Renewable Energy Revenue Optimization Using Real-World European Market Data

PRF Technologies Unit DeepSolar Completes Initial Validation Phase For Its Predict AI Revenue Optimization Platform

PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark

PRF Technologies Announces PRF-110 And ZYNRELEF Show Reductions In Mechanical Sensitivity Its Previously Reported Preclinical Trial; PRF-110 Demonstrated Slower Absorption Rate Relative To ZYNRELEF; PRF-110 Raise Retention In Local Tissue

PRF Technologies Signs $15M Standby Equity Purchase Agreement With Yorkville

Why Is PRF Tech Stock Falling On Monday?

PRF Technologies (PRFX) Shares Surge Over 186% After Hours: Here's What Is Going On

PRF Technologies Advances DeepSolar Predict™ Toward Commercial Launch as AI Platform Targets Revenue Optimization Across Renewable Energy Markets

PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study

PRF Technologies Announces Results From A Preclinical Study In Domestic Pigs Directly Comparing Its Lead Product Candidate, PRF-110, To ZYNRELEF

EXCLUSIVE: PRF Technologies Advances Drop-Less Drug For Cataract Surgery Pain

PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial

EXCLUSIVE: PRF Technologies Advances Drop-Less Drug For Cataract Surgery Pain

EXCLUSIVE: PRF Technologies Announces FDA Clearance Of IND Application For OcuRing-K Phase II Clinical Trial